Copy Link Print Information

Siplizumab

(Synonyms: MEDI-507; TCD601)
Revisión del cliente

Based on 1 Customer Validation

Siplizumab (MEDI-507) is a humanized IgG1 monoclonal antibody against CD2. Siplizumab depletes T cells, decreases T cell activation, inhibites T cell proliferation and enriches naïve and bona fide regulatory T cells.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: 99.83%
  • No. CAS: 288392-69-8
  • Peso molecular:146.25 kDa
  • Almacenamiento:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Siplizumab
  • Experimental Validation Results for Siplizumab
  • Experimental Validation Results for Siplizumab
  • Siplizumab Chemical Structure
    Siplizumab Chemical Structure
No. CAS: 288392-69-8
Tamaño
Precio
Stock
Cantidad
Amount: USD 0.00
Please select quantity
or
or

* Seleccione Cantidad antes de agregar artículos.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Siplizumab Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Encuentre su distribuidor local Your local distributor: Hycultec GmbHHycultec
  • Actividad biológica
  • Chemical Information
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
Top Publications Citing

Use of MCE Products

Keywords

MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Inicie sesiòn
Registrar
Sign in to MedChemExpress
Registrar una cuenta nueva

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    Human IgG1 kappa

  • 1/16

    Immobilized Human CD2 Protein (ECD, His Tag) can bind Siplizumab. The EC50 for this effect is 1.441 ng/mL.

  • 1/16

    Loaded Siplizumab on AHC2 biosensor, can bind CD2 Protein, Human (HEK293, His, HY-P7882) with an affinity constant of 3.775E-09 M as determined in BLI assay.

  • Siplizumab Chemical Structure
    1/16
  • Siplizumab
  • Immobilized Human CD2 Protein (ECD, His Tag) can bind Siplizumab. The EC50 for this effect is 1.441 ng/mL.
  • Loaded Siplizumab on AHC2 biosensor, can bind CD2 Protein, Human (HEK293, His, HY-P7882) with an affinity constant of 3.775E-09 M as determined in BLI assay.